Source: International Congress 2019 – Evaluation of basic science in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Patarin (Grenoble, France), É. Ghiringhelli (Grenoble, France), G. Darsy (Grenoble, France), M. Obamba (Grenoble, France), M. Robert de Saint Vincent (Grenoble, France), J. Cracowski (Grenoble, France), B. Camara (Grenoble, France), S. Quétant (Grenoble, France), J. Quésada (Grenoble, France), C. Cracowski (Grenoble, France). Comparing sputum rheology and spirometry as pathological markers in respiratory diseases. 1709

Member's Comments

No comment yet.

Related content which might interest you: Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Change of biochemical parameters of sputum in patients with different types of COPD exaserbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Correlation of biological markers of inflammation in peripheral blood with bronchoprovocative testing with histamine in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 287s Year: 2004 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Sputum cell counts and exacerbations of airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 485s Year: 2005 Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Roles of bronchoscopy and noninvasive measurements of airway inflammation in evaluating chronic cough: the role of noninvasive measurements of airway inflammation Source: Annual Congress 2007 - PG23 - Managing chronic cough: guidelines and controversies (jointly organised with ACCP) Year: 2007 Comparison of blood and sputum analysis in evaluation of eosinophilic COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005